A research team from the Korea Advanced Institute of Science and Technology (KAIST) has developed a robot skin that can sense external tactile stimuli and recover from injury when damaged.
The newly developed robot skin can sense pressure and vibration in real time with a small number of measuring elements by mimicking the structure of human skin and the properties and composition of tactile receptors.
By processing measured tactile signals through an artificial intelligence (AI)-based neural network, it can also classify the types of tactile stimuli such as pressing, tapping, and patting.
The robot skin, made of soft materials such as hydrogel and silicone, can absorb shock and easily recover structure and function even when it is torn or cut deeply by a sharp object.
The research team expects the robot skin to be used for restaurant serving robots and human-type robots that interact with humans because it can provide accurate tactile sensation over a large area and have material properties and textures that are similar to human skin.
When used on a prosthetic hand or leg, the robot skin can mimic the appearance and feel of real skin.


Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave
Asian Stocks Rebound as Trump Delays Iran Strike Deadline
WTO Reform Talks Begin in Cameroon Amid Global Trade Tensions
Global Flight Cancellations 2026: Middle East Air Travel Chaos Explained
How the war in Iran is already affecting UK farmers and food production
Dollar Strengthens as U.S.-Iran Peace Talks Send Mixed Signals
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Meta Ties Executive Pay to Aggressive Stock Price Targets in Major Retention Push
Oil Prices Slip as Trump Extends Iran Ceasefire Deadline Amid Ongoing War Fears
U.S. Praises Kurdistan's Role in Oil Markets Amid Iran War Fallout
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Neuralink Expands Brain Implant Trials with 12 Global Patients
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 



